Gut Mesenchymal Stromal Cells in Immunity

Area of Science:

• Immunology
• Gastroenterology
• Cell Biology

Background:

• Mesenchymal stromal cells (MSCs) are crucial for organ structure and immune homeostasis.
• Tissue-specific MSCs, including those in the bowel, interact closely with immune cells.
• In Crohn's disease, intestinal MSCs are exposed to chronic inflammation.

Purpose of the Study:

• To investigate the phenotypic changes of intestinal MSCs in Crohn's disease.
• To understand the role of inflammation and interferon-gamma in MSC behavior.
• To explore the consequences of MSC phenotype reversal on intestinal structure and disease progression.

Main Methods:

• Characterization of intestinal MSC phenotype in Crohn's disease.
• Analysis of the inflammatory milieu and its effect on MSCs.
• Investigation of Class II Major Histocompatibility Complex (MHC) expression on MSCs.

Main Results:

• Intestinal MSCs in Crohn's disease exhibit enforced Class II MHC expression, unlike normal MSCs.
• Interferon-gamma (IFNγ) induces Class II MHC expression on intestinal MSCs.
• This phenotype reversal transforms MSCs from immune-modulators to immune-activators, promoting fibrosis.

Conclusions:

• Crohn's disease-associated inflammation drives intestinal MSCs to an immune-activating phenotype.
• This MSC activation contributes to intestinal fibrosis and structural subversion.
• The altered MSC phenotype may increase the risk of dysplasia and cancer in Crohn's disease.